MEDICAMEQ — Medicamen Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual balance sheet for Medicamen Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	17.1	16.6	38.2	208	148
Net Total Accounts Receivable
Net Total Receivables	773	791	848	887	598
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,041	960	1,230	1,634	1,596
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	739	894	921	918	910
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,813	1,940	2,257	2,785	2,945
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	565	533	727	826	910
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	601	611	792	851	940
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,212	1,329	1,465	1,934	2,005
Total Liabilities & Shareholders' Equity	1,813	1,940	2,257	2,785	2,945
Total Common Shares Outstanding